Dicerna Pharmaceuticals, Inc. DRNA
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 2.98B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -19.11
- Beta
- 0.79
- Short ratio
- 0.84
- Inst. own
- 88.54%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2021
- 50-d avg
- 31.45
- 200-d avg
- 28.97
- 1y target
- 38.25
News
4 years ago businesswire.com
Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acquisition
LEXINGTON, Mass.--(BUSINESS WIRE)--Novo Nordisk today announced that the acquisition of Dicerna Pharmaceuticals, Inc. (Dicerna; Nasdaq: DRNA), announced on 18 November 2021, has been completed.…
-
4 years ago businesswire.com
Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acquisition
LEXINGTON, Mass.--(BUSINESS WIRE)--Novo Nordisk today announced that the acquisition of Dicerna, announced on 18 November 2021, has been completed.
4 years ago businesswire.com
Dicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk Tender Offer to Acquire Dicerna
LEXINGTON, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended…
4 years ago businesswire.com
Dicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk Tender Offer to Acquire Dicerna
LEXINGTON, Mass.--(BUSINESS WIRE)--Dicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk Tender Offer to Acquire Dicerna
4 years ago gurufocus.com
Shares of RNAi Drug Companies Pop After Novo Lays Out $3.3 Billion for Dicerna
Novo Nordisk AS ( NVO , Financial) is shelling out $3.3 billion to buy partner Dicerna Pharmaceuticals Inc. ( DRNA , Financial). That's $38.25 per share in cash, an 80% premium to the $21.28 closing…
4 years ago prnewswire.com
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Dicerna Pharmaceuticals, Inc. - DRNA
NEW YORK, Nov. 22, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class…
4 years ago zacks.com
Novo Nordisk (NVO) Set to Acquire Dicerna for $3.3 Billion
Novo Nordisk (NVO) inks agreement to acquire Dicerna for $3.3 billion. The company is looking to boost its RNAi research platform with this acquisition.
4 years ago prnewswire.com
SHAREHOLDER ALERT: WeissLaw LLP Investigates Dicerna Pharmaceuticals, Inc.
NEW YORK, Nov. 18, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Dicerna Pharmaceuticals, Inc.…
4 years ago newsfilecorp.com
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Sale of Dicerna Pharmaceuticals, Inc. to Novo Nordisk
New York, New York--(Newsfile Corp. - November 18, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who purchased Dicerna Pharmaceuticals, Inc.…
4 years ago invezz.com
Dicerna Pharmaceuticals acquired by Novo Nordisk; Shares rocket 80%
Dicerna Pharmaceuticals (Nasdaq: DRNA) is a biopharma company that concentrates on developing RNAi therapeutics that announced that Novo Nordisk would acquire it for a total equity value of about…
4 years ago fool.com
Why Dicerna Pharmaceuticals Stock Is Rocketing Higher Today
A juicy buyout offer from Novo Nordisk is giving Dicerna shareholders a big reason to cheer.
4 years ago investorplace.com
LCID, RIVN, FSR: Why Are EV Stocks Down Today?
We're taking a look at why EV stocks are down today and there are a couple of reasons shares of investors' favorites are falling. The post LCID, RIVN, FSR: Why Are EV Stocks Down Today?
4 years ago prnewswire.com
Shareholder Alert: Ademi LLP investigates whether Dicerna Pharmaceuticals, Inc. has obtained a Fair Price in its going private transaction with Novo Nordisk
MILWAUKEE, Nov. 18, 2021 /PRNewswire/ -- Ademi LLP is investigating Dicerna (Nasdaq: DRNA), for possible breaches of fiduciary duty and other violations of law in its transaction with Novo Nordisk.…
4 years ago businesswire.com
Dicerna Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Dicerna Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – DRNA
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) to Novo Nordisk for $38.25 per share…
4 years ago investorplace.com
DRNA Stock: The $3B Novo Nordisk Deal That Has Dicerna Pharma Shares Skyrocketing Today
Dicerna Pharmaceuticals (DRNA) stock is surging higher on Thursday following news of a massive $3.3 billion deal with Novo Nordisk. The post DRNA Stock: The $3B Novo Nordisk Deal That Has Dicerna…
4 years ago benzinga.com
Novo Nordisk Swallows Dicerna In $3.3B Buyout: All You Need To Know
Novo Nordisk A/S (NYSE: NVO) has agreed to acquire Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) for $38.25 per share in cash, representing a total equity value of $3.3 billion and a premium of 80% to…
4 years ago pulse2.com
Why Novo Nordisk (NVO) Is Buying Dicerna Pharmaceuticals (DRNA) For $3.3 Billion
Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) announced it entered into a definitive agreement with Novo Nordisk A/S (NYSE: NVO) under which Novo Nordisk will acquire Dicerna. This is why.
4 years ago marketwatch.com
Novo Nordisk strikes $3.3 billion to buy research partner Dicerna Pharmaceuticals
Novo Nordisk NVO, +0.37% NOVO.B, +0.69% said it's buying Dicerna Pharmaceuticals DRNA, -0.09% for $3.3 billion, or $38.25 per share in cash. Dicerna ended Wednesday at $21.28.
4 years ago businesswire.com
Novo Nordisk to Acquire Dicerna
LEXINGTON, Mass.--(BUSINESS WIRE)--DRNA announces definitive agreement with Novo Nordisk to be acquired for $38.25 per share in cash, which represents total equity value of $3.3 billion
-
4 years ago benzinga.com
Earnings Scheduled For November 9, 2021
Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter. • KT (NYSE:KT) is projected to report earnings for its third quarter.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
During Tuesday's morning session, 124 stocks hit new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET on Thursday, 145 companies set new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET on Tuesday, 125 stocks hit new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
During Monday's morning session, 255 companies made new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
During Friday's morning session, 235 stocks hit new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Tuesday morning saw 244 companies set new 52-week highs.
-
5 years ago benzinga.com
Earnings Scheduled For May 6, 2021
Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Friday's morning session saw 136 companies set new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Friday's morning session saw 420 companies set new 52-week highs.
-
5 years ago benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For April 16, 2021
Benzinga's Top Ratings Upgrades, Downgrades For April 16, 2021
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
During Monday's morning session, 230 companies made new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET Thursday, 371 stocks hit new 52-week highs.
-
5 years ago benzinga.com
Earnings Scheduled For November 5, 2020
Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stock (AMEX:BRG) is expected to report quarterly loss at $0.64 per share on revenue of $52.59 million.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Stocks That Hit 52-Week Highs On Friday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
Stocks That Hit 52-Week Highs On Monday
-
8 years ago benzinga.com
Stocks Which Set New 52-Week High Friday, September 14th
Stocks Which Set New 52-Week High Friday, September 14th
-
8 years ago benzinga.com
Stocks Which Set New 52-Week High Yesterday, September 5th
Stocks Which Set New 52-Week High Yesterday, September 5th
-
8 years ago benzinga.com
Stocks Which Set New 52-Week High Yesterday, August 15th
Stocks Which Set New 52-Week High Yesterday, August 15th